Ensign Group (ENSG) free cash flow

Free cash flow · fiscal 2025
$370.71M

Ensign Group (ENSG) generated free cash flow of $370.71M in fiscal 2025 (the year ended December 31, 2025). That is 96.2% higher than the $188.95M of fiscal 2024. Figures as of 18 Nov 2026, 12:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$370.71M
Change on fiscal 2024
+96.2%
Highest on record
$370.71Mfiscal 2025
Lowest on record
-$26.65Mfiscal 2015
Fiscal years on record
152009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Ensign Group free cash flow, in more detail

Across the 15 fiscal years on record (2009–2025), the highest was $370.71M in fiscal 2025 and the lowest -$26.65M in fiscal 2015.

History · 15 fiscal years

Free cash flow by fiscal year

Ensign Group free cash flow, year by year

Ensign Group (ENSG) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$370.71M 96.2% up
2024$188.95M 30.1% down
2023$270.49M 46.2% up
2022$184.97M—
2019$120.68M 24.3% down
2018$159.41M 526.0% up
2017$25.46M 211.0% up
2016$8.19M—
2015-$26.65M 185.4% down
2014$31.19M 306.9% up
2013$7.67M 82.3% down
2012$43.20M 35.4% up
2011$31.91M 0.4% up
2010$31.78M 30.3% up
2009$24.39M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Ensign Group and comparable companies
CompanyFree cash flowFiscal year
Avantor AVTR$495.00M2025
Ensign Group ENSG$370.71M2025
Vaxcyte PCVX-$712.55M2025
Bio-Rad Laboratories BIO$374.60M2025
Molina Healthcare MOH-$636.00M2025
Spyre Therapeutics SYRE-$169.25M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ENSG

Ensign Group, figure by figure

Ensign Group (ENSG) overview: price, valuation and scorecardAll health care companies by market value

Ensign Group free cash flow: questions and answers

What is Ensign Group's free cash flow?

Ensign Group (ENSG) generated free cash flow of $370.71M in fiscal 2025 (the year ended December 31, 2025). That is 96.2% higher than the $188.95M of fiscal 2024.

What are the highest and lowest free cash flow figures on record for Ensign Group?

Across the 15 fiscal years on record (2009–2025), the highest was $370.71M in fiscal 2025 and the lowest -$26.65M in fiscal 2015.

How is Ensign Group's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Ensign Group it is on record here for 15 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ensign Group (ENSG) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/ENSG/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.